Welcome to our dedicated page for Livecare news (Ticker: LVCE), a resource for investors and traders seeking the latest updates and insights on Livecare stock.
LiveCare Inc. (LVCE) generates news as a telehealth and healthcare technology company focused on remote patient monitoring, health coaching, and chronic disease management. Coverage of LiveCare often centers on its programs for individuals with Type 2 diabetes, high blood pressure, hypertension, congestive heart failure, and other chronic conditions, delivered through 24/7 telehealth support and connected monitoring devices.
News updates frequently highlight patient growth milestones, expansion of services into additional U.S. states, and efforts to extend telehealth offerings nationwide. Articles also describe LiveCare’s development and launch of a blood pressure cuff device designed for people with high blood pressure and related conditions, as well as its broader use of non-invasive monitoring technologies linked to its health center and live professionals.
Investors and observers can find reports on LiveCare’s financial and operational milestones, including recurring monthly revenue achievements, patient acquisition metrics, and stated goals related to profitability and aspirations to become a fully reporting NASDAQ entity. The company’s expansion initiatives into markets such as Florida, Texas, Ohio, Michigan, California, and the Gulf region via provisional approval in Dubai Healthcare City are also recurring themes.
Another important category of news involves regulatory and compliance developments. LiveCare has publicly discussed identifying potential non-compliance with Medicare rules, conducting an internal investigation, self-disclosing concerns about marketing practices, and cooperating with a U.S. Department of Justice investigation involving the Anti-Kickback Statute and the False Claims Act, which the company reports has been resolved with corrective actions in place.
This news page allows readers to follow LiveCare’s announcements on telehealth services, chronic disease programs, technology initiatives, geographic expansion, and compliance matters over time.
LiveCare Inc. (LVCE) has announced the resolution of a U.S. Department of Justice investigation regarding Anti-Kickback Statute and False Claims Act allegations. The investigation stemmed from a self-disclosure made by LiveCare in July 2023 after discovering potential non-compliance with Medicare rules for remote patient monitoring (RPM) services patient referrals.
The company conducted an internal investigation through external healthcare enforcement attorneys, which identified several risk areas requiring attention. LiveCare proactively disclosed these concerns about marketing practices to the U.S. Department of Health and Human Services Office of the Inspector General.
In response, LiveCare implemented corrective actions, including significant changes to patient acquisition methods and RPM service billing practices. CEO Max Rockwell emphasized the company's commitment to compliance and ethical business practices, highlighting the implementation of enhanced compliance measures to ensure continued operational integrity.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.